EMMA: Emmaus Life Sciences, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 5.81
Enterprise Value ($M) 34.15
Book Value ($M) -56.48
Book Value / Share -0.88
Price / Book -0.10
NCAV ($M) -73.31
NCAV / Share -1.15
Price / NCAV -0.08

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) -0.22
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 0.08
Current Ratio 0.11

Balance Sheet (mrq) ($M)
Current Assets 6.77
Assets 23.60
Liabilities 80.08
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 16.65
Operating Income -1.89
Net Income -6.45
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -2.29
Cash from Investing 2.50
Cash from Financing -1.35

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-04 13G/A Lim Seah H. 6.50 -9.58

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-07-03 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K

(click for more detail)

Similar Companies
ELOX – Eloxx Pharmaceuticals, Inc. ELTP – Elite Pharmaceuticals, Inc.
ELVAF – Evolva Holding SA ENZB – Enzo Biochem, Inc.
ENZN – Enzon Pharmaceuticals, Inc.


Financial data and stock pages provided by
Fintel.io